General MedicationsORALGeneric

VALPROIC ACID

Standard Dose

250MG

Max Dose

Refer to approved labeling

Primary Use

Review priority: STANDARD Marketing status: Discontinued

Summary

Approval overview VALPROIC ACID is listed in Drugs@FDA under application 207611 (ANDA).

Review priority: STANDARD Marketing status: Discontinued Active ingredient VALPROIC ACID Form and strength CAPSULE;ORAL - 250MG Sponsor HIBROW HLTHCARE Submission history Latest submission status date: 2026-03-31 00:00:00.

Structured Monograph

Clinical summary

Approval overview VALPROIC ACID is listed in Drugs@FDA under application 207611 (ANDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient VALPROIC ACID Form and strength CAPSULE;ORAL - 250MG Sponsor HIBROW HLTHCARE Submission history Latest submission status date: 2026-03-31 00:00:00. Submission type: SUPPL.

Monitoring

• Marketing status: Discontinued
• Review priority: STANDARD

Interaction Notes

No interaction notes stored yet.